"Advances in the Prevention and Treatment of Congenital Cytomegalovirus Infection" / (Record no. 13076)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01646nas a22002537a 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OSt |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20210318160934.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m|||||r|||| 00| 0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | ta |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 171219t2016 sp ||||| |||| 00| 0 spa | |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1531-698X |
040 ## - CATALOGING SOURCE | |
Transcribing agency | Salus Infirmorum |
245 00 - TITLE STATEMENT | |
Title | "Advances in the Prevention and Treatment of Congenital Cytomegalovirus Infection" / |
Statement of responsibility, etc. | Scott H. James, and David W. Kimberlin |
500 ## - GENERAL NOTE | |
General note | PDF en biblioteca |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc. note | Bibliografía: p. 7-9 |
520 8# - SUMMARY, ETC. | |
Summary, etc. | Purpose of review—Cytomegalovirus (CMV) is the most common cause of congenital infection in the world. Symptomatic infants are at increased risk of developing permanent sequelae, including sensorineural hearing loss (SNHL) and neurodevelopmental delay. Advances in the treatment and prevention of congenital CMV infection are a high priority nationally and globally.<br/>Recent findings—In symptomatic infants, antiviral therapy with 6 months of oral valganciclovir (VGCV) improves hearing and neurodevelopmental outcomes. Strategies to prevent congenital or maternal CMV infections, including the use of CMV hyperimmune globulin (HIG) and development of a maternal vaccine, have yet to yield positive results.<br/>Summary—The clinical significance of congenital CMV infection, developments in antiviral therapy, and efforts to prevent congenital disease are herein reviewed. |
653 14 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | Congenital cytomegalovirus |
653 14 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | Antiviral therapy |
653 14 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | Valganciclovir |
653 14 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | Vaccine |
653 14 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | Mother-to-child transmission |
773 ## - HOST ITEM ENTRY | |
Related parts | -- 2016, v. 28, 1, p. 81-5 |
Title | Current opinion in pediatrics |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Universal Decimal Classification |
Koha item type | Artículo de revista |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection code | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Universal Decimal Classification | Non-fiction | Revistas y artículos | Revistas y artículos | 18/03/2021 | PP | 5719 | 18/03/2021 | 18/03/2021 | Artículo de revista |